TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01649921 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02795572 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00443443 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00563290 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT01559090 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study NCT02733107 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02135757 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04643691 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04643691 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04643691 — Safety Biomarker (SAF): RAS pathway
Study NCT04066933 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study NCT04066933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02654145 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02654145 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02023203 — Predictive Biomarker (PRD): PPL mRNA
Genes: PPL; KIAA0568
Study NCT04206462 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02919462 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01065753 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01065753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01065753 — Safety Biomarker (SAF): BDNF
Study NCT04136028 — Safety Biomarker (SAF): Interleukin 1
Study NCT00005138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01007994 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00657852 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00549484 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03142022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02627963 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02627963 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01472432 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02696824 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02840149 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02188407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02188407 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02188407 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02188407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03820063 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02814071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02814071 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00204425 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04863144 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01698736 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT02483416 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02483416 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03097692 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05088772 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03535961 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04181866 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01859637 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00978536 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04440150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04440150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04440150 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04259970 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01116505 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03257228 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03257228 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study NCT02225015 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02225015 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04418219 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00529763 — Surrogate Endpoint (SUR): Hematologic response
Study NCT02959619 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01846091 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT01756716 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04064320 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00603967 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study NCT03095248 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT00925223 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00925223 — Safety Biomarker (SAF): BDNF
Study NCT02792790 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02344550 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02344550 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03790462 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00357461 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04076007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03456544 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04418167 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT00858780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03946787 — Safety Biomarker (SAF): BDNF
Study NCT03946787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03946787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00042835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05526313 — Predictive Biomarker (PRD): HDAC1 mRNA
Genes: HDAC1; RPD3L1
Study NCT05526313 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT05526313 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study NCT05526313 — Predictive Biomarker (PRD): HDAC10 mRNA
Genes: HDAC10
Study NCT05526313 — Predictive Biomarker (PRD): HDAC4 mRNA
Genes: HDAC4; KIAA0288
Study NCT05526313 — Predictive Biomarker (PRD): HDAC5 mRNA
Genes: HDAC5; KIAA0600
Study NCT05526313 — Predictive Biomarker (PRD): HDAC7 mRNA
Genes: HDAC7; HDAC7A
Study NCT05526313 — Predictive Biomarker (PRD): HDAC9 mRNA
Genes: HDAC9; HDAC7; HDAC7B; HDRP; KIAA0744; MITR
Study NCT05526313 — Predictive Biomarker (PRD): HDAC11 mRNA
Genes: HDAC11
Study NCT01942135 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01942135 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01942135 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01942135 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03485118 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03482180 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02429583 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01055990 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02359149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02424435 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT04967469 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03410485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03674606 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01592240 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03234127 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02042560 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02042560 — Predictive Biomarker (PRD): CXCR5 mRNA
Genes: CXCR5; BLR1; MDR15
Study NCT02042560 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT02266823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02266823 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01255215 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT03596710 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02588781 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02588781 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT02588781 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT00456898 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02483195 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT04388410 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04132115 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT00838838 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03791307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01225510 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT04403035 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02379494 — Predictive Biomarker (PRD): PAPPA mRNA
Genes: PAPPA
Study NCT02379494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT02379494 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02379494 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00926250 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04646447 — Predictive Biomarker (PRD): GRIN1 mRNA
Genes: GRIN1; NMDAR1
Study NCT04646447 — Predictive Biomarker (PRD): GRIN2A mRNA
Genes: GRIN2A; NMDAR2A
Study NCT04646447 — Predictive Biomarker (PRD): GRIN2B mRNA
Genes: GRIN2B; NMDAR2B
Study NCT04158128 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04158128 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT04158128 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study NCT04158128 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT04158128 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04158128 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT04158128 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04158128 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04980105 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00387192 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03302598 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02898987 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00748696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03528486 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT01719250 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02537379 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study NCT02849912 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02258035 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01213381 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT01476501 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03992183 — Predictive Biomarker (PRD): CAMLG mRNA
Genes: CAMLG; CAML; GET2
Study NCT03830450 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03830450 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04269122 — Surrogate Endpoint (SUR): Plasma ammonia
Study NCT01185158 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03353376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01780350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02946424 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02103920 — Predictive Biomarker (PRD): PSPH mRNA
Genes: PSPH
Study NCT02103920 — Predictive Biomarker (PRD): PSAT1 mRNA
Genes: PSAT1; PSA
Study NCT02103920 — Predictive Biomarker (PRD): SHMT1 mRNA
Genes: SHMT1
Study NCT02103920 — Predictive Biomarker (PRD): GLDC mRNA
Genes: GLDC; GCSP
Study NCT02704767 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02704767 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02938728 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02938728 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT01456962 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01456962 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT04633863 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00364728 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03795012 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00639119 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02020850 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02330549 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT02330549 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02330549 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT00881569 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03985098 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00109863 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00748566 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00748566 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02761915 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02060253 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02060253 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04637360 — Predictive Biomarker (PRD): BMP6 mRNA
Genes: BMP6; VGR
Study NCT04637360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study NCT04637360 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04637360 — Predictive Biomarker (PRD): CTHRC1 mRNA
Genes: CTHRC1; UNQ762/PRO1550
Study NCT04637360 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02519153 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00496340 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00682201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02758782 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03612154 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00981838 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02666976 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02666976 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04138251 — Predictive Biomarker (PRD): G6PC3 mRNA
Genes: G6PC3; UGRP
Study NCT01693952 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01693952 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01344031 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03993145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00136448 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03971305 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04289805 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00125918 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02888964 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02888964 — Predictive Biomarker (PRD): STAT5A mRNA
Genes: STAT5A; STAT5
Study NCT02888964 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02888964 — Predictive Biomarker (PRD): STAT5B mRNA
Genes: STAT5B
Study NCT03306758 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00813514 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00813514 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT01196390 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03786107 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03786107 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00143273 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00857779 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03217591 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03442920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03844906 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT03929302 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03929302 — Predictive Biomarker (PRD): ABCA7 mRNA
Genes: ABCA7
Study NCT02545530 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04560725 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03613038 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02573662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02573662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00925717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02760433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01859260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02498938 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01037231 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT02994147 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT02994147 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00603031 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00538109 — Predictive Biomarker (PRD): AMN mRNA
Genes: AMN; UNQ513/PRO1028
Study NCT04070807 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT01525628 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01525628 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01525628 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03080935 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01750827 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT03875495 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00989716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01811433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01232660 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00252161 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02609191 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04320745 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04438434 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01891357 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03622996 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05643391 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03279250 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02864836 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02620189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02620189 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT01502553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00452218 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03816449 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03816449 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03816449 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03816449 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02575456 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03892343 — Surrogate Endpoint (SUR): Blood pressure